Moreover, the impact of short-chain fatty acids (SCFAs) and succinate (microbial metabolites) on the microbiome promotes improvement in obesity-related insulin sensitivity in animals and influences mass control and glucose and lipid homeostasis in humans [74,75,76]. This evidence concerns the gene INS and obesity disorder.